Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Eprosartan Mesylate...
StayinFront, a global provider of Customer Relationship Management (CRM) and mobile sales force effectiveness tools, introduces StayinFront TouchCG™, the company's innovative mobile field force...